The Canadian Minister of Health has announced the appointment of Anie Perrault as Vice Chairperson of the Patented Medicine Prices Review Board (PMPRB). The appointment, made on August 15, 2023, will instate Perrault for a five-year term.
Perrault brings a wealth of experience to her new role, with a career spanning over three decades in the public and private sectors. She has held notable positions within Quebec’s genomic research and biotechnology sector, making significant contributions at a national level.
This timely appointment coincides with the publication of the Meds Entry Watch 7th Edition, signaling pivotal developments within the PMPRB. Perrault will undoubtedly leverage her expertise to lead strategically in this role, influencing the future direction of patented medicine prices in Canada.
For more detailed information regarding Perrault’s appointment and her distinguished expertise, as well as further insight into the broader implications of these updates for legal professionals and the wider healthcare industry, refer to the full report available here.